Exodus Point Capital Management, LP Ginkgo Bioworks Holdings, Inc. Transaction History

Exodus Point Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.28 - $1.16 $40,336 - $167,107	144,058 New	144,058 $48,000
Q2 2023 Aug 10, 2023	SELL	$1.14 - $1.95 $931,227 - $1.59 Million	-816,866 Reduced 96.67%	28,101 $52,000
Q1 2023 May 11, 2023	BUY	$1.2 - $2.19 $1.01 Million - $1.85 Million	844,967 New	844,967 $1.12 Million
Q3 2022 Nov 10, 2022	SELL	$0.73 - $3.74 $207,300 - $1.06 Million	-283,973 Closed	0 $0
Q2 2022 Aug 19, 2022	SELL	$2.2 - $4.2 $1.07 Million - $2.05 Million	-487,022 Reduced 63.17%	283,973 $676,000
Q1 2022 May 13, 2022	BUY	$2.83 - $8.69 $2.03 Million - $6.23 Million	717,414 Added 1338.93%	770,995 $3.11 Million
Q4 2021 Feb 11, 2022	BUY	$8.31 - $14.92 $445,258 - $799,428	53,581 New	53,581 $445,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $12.1B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.